OvaScience (OVAS) Bullish Stance Reiterated at Leerink Partners Post Q4

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. HNGE
9. INSP
10. SPY

Go back to OvaScience (OVAS) Bullish Stance Reiterated at Leerink Partners Post Q4

OvaScience Reports Fourth Quarter and Year End 2014 Financial Results

March 16, 2015 4:22 PM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported fourth quarter and year end 2014 financial results and highlighted recent accomplishments.

This past year was transformational for OvaScience and, most importantly, for the fertility patients we serve globally, said Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience. We introduced the first fertility treatment from our EggPC technology platform, the AUGMENT treatment, to patients in select international regions, providing women with a new option to address egg... More